Literature DB >> 28167669

Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.

Huynh A Hong1, Krisztina Hitri1, Siamand Hosseini1, Natalia Kotowicz2, Donna Bryan3, Fatme Mawas3, Anthony J Wilkinson4, Annie van Broekhoven5, Jonathan Kearsey6, Simon M Cutting7.   

Abstract

Mucosal immunity is considered important for protection against Clostridium difficile infection (CDI). We show that in hamsters immunized with Bacillus subtilis spores expressing a carboxy-terminal segment (TcdA26-39) of C. difficile toxin A, no colonization occurs in protected animals when challenged with C. difficile strain 630. In contrast, animals immunized with toxoids showed no protection and remained fully colonized. Along with neutralizing toxins, antibodies to TcdA26-39 (but not to toxoids), whether raised to the recombinant protein or to TcdA26-39 expressed on the B. subtilis spore surface, cross-react with a number of seemingly unrelated proteins expressed on the vegetative cell surface or spore coat of C. difficile These include two dehydrogenases, AdhE1 and LdhA, as well as the CdeC protein that is present on the spore. Anti-TcdA26-39 mucosal antibodies obtained following immunization with recombinant B. subtilis spores were able to reduce the adhesion of C. difficile to mucus-producing intestinal cells. This cross-reaction is intriguing yet important since it illustrates the importance of mucosal immunity for complete protection against CDI.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Clostridium difficile; colonization; immune exclusion; mucosal immunity; oral vaccines

Mesh:

Substances:

Year:  2017        PMID: 28167669      PMCID: PMC5364299          DOI: 10.1128/IAI.01060-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Mucosal antibody responses in experimental hookworm infection.

Authors:  R D Bungiro; T Sun; L M Harrison; C B Shoemaker; M Cappello
Journal:  Parasite Immunol       Date:  2008-02-28       Impact factor: 2.280

2.  Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.

Authors:  Patima Permpoonpattana; Huynh A Hong; Jutarop Phetcharaburanin; Jen-Min Huang; Jenny Cook; Neil F Fairweather; Simon M Cutting
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 3.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

4.  Conserved supersecondary structural motif in NAD-dependent dehydrogenases.

Authors:  A S Kutzenko; V S Lamzin; V O Popov
Journal:  FEBS Lett       Date:  1998-02-13       Impact factor: 4.124

Review 5.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

6.  Colonization for the prevention of Clostridium difficile disease in hamsters.

Authors:  Susan P Sambol; Michelle M Merrigan; Janet K Tang; Stuart Johnson; Dale N Gerding
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

7.  Identification of proteins in the exosporium of Bacillus anthracis.

Authors:  Caroline Redmond; Leslie W J Baillie; Stephen Hibbs; Arthur J G Moir; Anne Moir
Journal:  Microbiology       Date:  2004-02       Impact factor: 2.777

8.  Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model.

Authors:  Claire Colenutt; Simon M Cutting
Journal:  FEMS Microbiol Lett       Date:  2014-05-29       Impact factor: 2.742

9.  Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.

Authors:  Natalie G Anosova; Anna M Brown; Lu Li; Nana Liu; Leah E Cole; Jinrong Zhang; Hersh Mehta; Harry Kleanthous
Journal:  J Med Microbiol       Date:  2013-03-21       Impact factor: 2.472

10.  Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.

Authors:  Lisa F Dawson; Esmeralda Valiente; Alexandra Faulds-Pain; Elizabeth H Donahue; Brendan W Wren
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more
  14 in total

Review 1.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

2.  Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

Authors:  Caixia Tan; Fei Zhu; Yuanyuan Xiao; Yuqi Wu; Xiujuan Meng; Sidi Liu; Ting Liu; Siyao Chen; Juan Zhou; Chunhui Li; Anhua Wu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.

Authors:  Shaohui Wang; Duolong Zhu; Xingmin Sun
Journal:  Microbiol Spectr       Date:  2022-05-18

4.  Adaptive immune constraints on C. difficile vaccination.

Authors:  Mark L Lang; Binu Shrestha
Journal:  Expert Rev Vaccines       Date:  2017-09-19       Impact factor: 5.217

5.  Biological Containment of Genetically Modified Bacillus subtilis.

Authors:  Siamand Hosseini; Alex Curilovs; Simon M Cutting
Journal:  Appl Environ Microbiol       Date:  2018-01-17       Impact factor: 4.792

Review 6.  Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Authors:  Karin Hoelzer; Lisa Bielke; Damer P Blake; Eric Cox; Simon M Cutting; Bert Devriendt; Elisabeth Erlacher-Vindel; Evy Goossens; Kemal Karaca; Stephane Lemiere; Martin Metzner; Margot Raicek; Miquel Collell Suriñach; Nora M Wong; Cyril Gay; Filip Van Immerseel
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

7.  Recent advances in the treatment of C. difficile using biotherapeutic agents.

Authors:  Vo Van Giau; Hyon Lee; Seong Soo A An; John Hulme
Journal:  Infect Drug Resist       Date:  2019-06-10       Impact factor: 4.003

8.  Vaccination against Clostridium difficile by Use of an Attenuated Salmonella enterica Serovar Typhimurium Vector (YS1646) Protects Mice from Lethal Challenge.

Authors:  Kaitlin Winter; Li Xing; Audrey Kassardjian; Brian J Ward
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

9.  Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice.

Authors:  Changjiao Gan; Wenbo Luo; Yunzhou Yu; Zhouguang Jiao; Sha Li; Duo Su; Junxia Feng; Xiaodong Zhao; Yefeng Qiu; Lingfei Hu; Dongsheng Zhou; Xiaolu Xiong; Jinglin Wang; Huiying Yang
Journal:  NPJ Vaccines       Date:  2021-06-22       Impact factor: 7.344

10.  The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile.

Authors:  Huynh A Hong; William T Ferreira; Siamand Hosseini; Saba Anwar; Krisztina Hitri; Anthony J Wilkinson; Wilfried Vahjen; Jürgen Zentek; Mikhail Soloviev; Simon M Cutting
Journal:  J Infect Dis       Date:  2017-12-12       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.